Recent news on

Bayer HealthCare and Intendis Announce Strategic Alliance to Co ...  -  May 7, 2007
PharmaLive.com (press release),...jointly promote YAZ(R) (drospirenone/ethinyl estradiol) as a treatment for moderate acne in women who desire an oral contraceptive for birth control.

Bayer Schering gets fresh approvals for two contraceptives  -  Jan 30, 2007
Pharma Times (subscription),...a new indication for Yaz (drospirenone/ethinyl estradiol) to treat moderate acne vulgaris in women who desire an oral contraceptive for birth control.

FDA Approvals: Yaz, Betaseron, and Nexium  Nov 2, 2006
The US Food and Drug Administration (FDA) has approved a new indication for a 24-day active hormone regimen of drospirenone/ethinyl estradiol tablets, allowing ... -Medscape (subscription) John Spetrino Named Chief Creative Officer at Flashpoint Medica  Aug 23, 2006
...who added that Spetrino's track record includes the blockbuster launches of Avandia (rosiglitazone), Yasmin (drospirenone/ethinyl estradiol) and Biaxin ... -Yahoo! News

John Spetrino Named Chief Creative Officer at Flashpoint Medica  Aug 23, 2006
...track record includes the blockbuster launches of Avandia (rosiglitazone), Yasmin (drospirenone/ethinyl estradiol) and Biaxin (clarithromycin). ... -PharmaLive.com



Pipeline Insight: Anxiety Disorders - A decade of declining ...  Mar 28, 2006
Predix's PRX-00023 (oral non-azapirone 5-HT1A agonist) in Phase III for GAD, and Schering AG/Berlex's YAZ (low dose drospirenone/ethinyl estradiol) and Wyeth's ... - Pharmaceutical Business Review

Schering's Yaz wins US green light  Mar 17, 2006
Yaz (drospirenone/ethinyl estradiol), a member of the group's Yasmin franchise of low-dose contraceptives, is the first pill which combines the innovative ... - Pharma Times (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional